Cargando…
What is the effect of adjusting epirubicin doses for body surface area?
Doses of cytotoxic drugs are routinely adjusted according to body surface area. We have evaluated this practice in 32 women with advanced breast cancer treated with single-agent epirubicin 12.5-120 mg m(-2). Epirubicin and its metabolites were measured by high-performance liquid chromatography (HPLC...
Autores principales: | Dobbs, N. A., Twelves, C. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063057/ https://www.ncbi.nlm.nih.gov/pubmed/9744507 |
Ejemplares similares
-
Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
por: Twelves, C. J., et al.
Publicado: (1992) -
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?
por: Dobbs, N. A., et al.
Publicado: (1998) -
Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.
por: Twelves, C. J., et al.
Publicado: (1989) -
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
por: Arshad, Usman, et al.
Publicado: (2021) -
Epirubicin
por: Cornish, J., et al.
Publicado: (1988)